Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068366 · ClinicalTrials.gov registry record
Nickel Allergy With Septal Closure Devices
A clinical trial, sponsored by University of Utah.
- Terminated
- Registry status
- 4
- Enrollment target
NCT01068366 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 4 participants.
The verdict
NCT01068366 was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study is for patients who have been diagnosed with either a Patent Foramen Ovale \[PFO\] or an Atrial Septal Defect \[ASD\]. These are a type of hole located in the wall that separates the top two (2) chambers of the heart. You have been recommended to receive an atrial septal occluder device \[a device specifically designed to close PFOs and ASDs\] implanted in your heart to close this hole. Because these devices are made of materials that contain nickel, this trial is being conducted to perform blood nickel tests on those patients already referred for an atrial septal occluder device such as yourself. The purpose of this study is to compare levels of nickel in the blood in patients receiving either the Amplatzer or the Helex devices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-02 |
| Est. Completion | 2010-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068366
The ClinicalTrials.gov registry entry for NCT01068366 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01068366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01068366 about?
NCT01068366 is a clinical study titled "Nickel Allergy With Septal Closure Devices". This study is for patients who have been diagnosed with either a Patent Foramen Ovale \[PFO\] or an Atrial Septal Defect \[ASD\]. These are a type of hole located in the wall that separates the top two (2) chambers of the heart. You have been recommended to receive an atrial septal occluder device \...
What is the current status of trial NCT01068366?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2010-02. Estimated completion is 2010-11.
Who is sponsoring clinical trial NCT01068366?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.